Sandercock Brett 4
4 · RESMED INC · Filed Oct 3, 2025
Insider Transaction Report
Form 4
RESMED INCRMD
Sandercock Brett
Chief Financial Officer
Transactions
- Exercise/Conversion
ResMed Common Stock
2025-10-01$101.64/sh+2,000$203,280→ 89,745 total - Exercise/Conversion
ResMed Common Stock Options
2025-10-01−2,000→ 2,000 totalExercise: $101.64From: 2019-11-11Exp: 2025-11-14→ ResMed Common Stock (2,000 underlying) - Sale
ResMed Common Stock
2025-10-01$274.36/sh−3,000$823,080→ 86,745 total
Footnotes (2)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
- [F2]Represents date options first become exercisable. Options vest 1/3 per year.